Can my doctor request an expedited appeal?

Yes - and it's often more effective than the patient asking. The provider's explicit statement that delay would cause harm triggers the 72-hour decision deadline. Many denials are reversed at this peer-to-peer phone call between the ordering provider and the insurer's medical director, even before written appeal. Ask your provider to request the peer-to-peer.

What if my appeal is denied?

Two paths: (1) Second-level internal appeal (some plans offer; ACA only requires one internal level). (2) External review by Independent Review Organization (IRO) - required for ACA non-grandfathered plans, free to the patient, decision binding on insurer. Externally-reversed denials are 40-50% per published data. Filing a state Insurance Commissioner complaint can accelerate the process. For chronic situations, lawsuit under ERISA or state insurance law is the final option (engage healthcare attorney).

Usually not for simple medical-necessity appeals. For complex denials - experimental/investigational for serious illness, repeated denials, or denials affecting urgent treatment - working with healthcare attorneys, patient-advocacy organizations (Patient Advocate Foundation), or non-profit help (Cancer Legal Resource Center for oncology, ALS Association for ALS, etc.) significantly improves outcomes. Many work on contingency or low-cost.

Should the doctor write the letter?

A "letter of medical necessity" from the ordering provider is one of the most important attachments. It should specifically address the denial reason, cite the patient's clinical history, and explain why the service is medically necessary. Patient-written appeals supplement but don't replace provider letters - committee reviewers weight provider documentation heavily.

How does external review work?

After internal-appeals exhaustion, the patient (or provider) requests external review. The state DOI (or for self-funded plans, federal HHS) refers the case to an independent IRO - a third-party clinical reviewer with no relationship to the insurer or patient. The IRO reviews the case and issues a binding decision typically within 45 days (5 days for urgent). Free to the patient; insurer pays the IRO fee. External review is the patient's most effective post-internal-appeals option.

Can my doctor request an expedited appeal?

Yes - and it's often more effective than the patient asking. The provider's explicit statement that delay would cause harm triggers the 72-hour decision deadline. Many denials are reversed at this peer-to-peer phone call between the ordering provider and the insurer's medical director, even before written appeal. Ask your provider to request the peer-to-peer.

What if my appeal is denied?

Two paths: (1) Second-level internal appeal (some plans offer; ACA only requires one internal level). (2) External review by Independent Review Organization (IRO) - required for ACA non-grandfathered plans, free to the patient, decision binding on insurer. Externally-reversed denials are 40-50% per published data. Filing a state Insurance Commissioner complaint can accelerate the process. For chronic situations, lawsuit under ERISA or state insurance law is the final option (engage healthcare attorney).

Usually not for simple medical-necessity appeals. For complex denials - experimental/investigational for serious illness, repeated denials, or denials affecting urgent treatment - working with healthcare attorneys, patient-advocacy organizations (Patient Advocate Foundation), or non-profit help (Cancer Legal Resource Center for oncology, ALS Association for ALS, etc.) significantly improves outcomes. Many work on contingency or low-cost.

Should the doctor write the letter?

A "letter of medical necessity" from the ordering provider is one of the most important attachments. It should specifically address the denial reason, cite the patient's clinical history, and explain why the service is medically necessary. Patient-written appeals supplement but don't replace provider letters - committee reviewers weight provider documentation heavily.

How does external review work?

After internal-appeals exhaustion, the patient (or provider) requests external review. The state DOI (or for self-funded plans, federal HHS) refers the case to an independent IRO - a third-party clinical reviewer with no relationship to the insurer or patient. The IRO reviews the case and issues a binding decision typically within 45 days (5 days for urgent). Free to the patient; insurer pays the IRO fee. External review is the patient's most effective post-internal-appeals option.

Health Insurance Prior Authorization Appeal

Appeal of a prior-authorization denial for a specific medical service - drug, procedure, or DME.

Customise

Member name

Member / policy ID

Group number

Member DOB

Member address

Phone

Insurer name

Insurer appeals department address

Denial reference / authorization number

Denial date

Service / drug / DME requested

Ordering provider

Reason given for denial

Medical necessity argument

Requested remedy

Attachments

Live preview

Jordan Alex Taylor
482 Elm Street, Apt 3B, Portland, OR 97214
Phone: +1 503 555 0118

Date: June 19, 2026

To:    BlueCross BlueShield Oregon
       BCBSOR Appeals Department, P.O. Box 30001, Lewiston, ID 83501

Re:    PRIOR AUTHORIZATION APPEAL
       Member:        Jordan Alex Taylor
       Member ID:     88312-Q
       Group:         GRP-OR-44218
       DOB:           June 12, 1985
       Denial ref:    PA-DENIED-2026-04481
       Denial date:   April 22, 2026

═══════════════════════════════════════════════════════════════════════

To the Appeals Department,

I am formally appealing the prior-authorization denial referenced above.

═══════════════════════════════════════════════════════════════════════

SERVICE DENIED

  Wegovy (semaglutide 2.4 mg) for chronic weight management - 12-week initial supply

  Ordering provider:     Dr. Lin Chen, MD - OHSU Internal Medicine

═══════════════════════════════════════════════════════════════════════

DENIAL REASON GIVEN

Insurer cited Coverage Policy 4.02.18 - "Medication not covered for member's diagnostic profile. Member does not meet criteria for clinical obesity treatment under plan medical policy: documented BMI ≥35, OR BMI ≥30 with one obesity-related comorbidity, AND failure of at least 6 months of supervised diet/exercise program."

═══════════════════════════════════════════════════════════════════════

MEDICAL NECESSITY ARGUMENT

I meet ALL the cited coverage policy criteria:
  - Current BMI: 31.2 (above the 30 threshold).
  - Documented obesity-related comorbidities: Type 2 prediabetes (A1C 6.2 documented 2025-08), hypertension (controlled on lisinopril 10 mg, documented 2024-12).
  - Supervised diet/exercise: I have completed 8 months of a structured weight-management program through OHSU Wellness Clinic (records 2025-09 through 2026-04, attached). Modest weight loss achieved (~5 lbs); program providers documented that pharmacotherapy is now appropriate.
Clinical guidelines (American Gastroenterological Association 2022, ADA Standards of Care 2024-2025) explicitly support semaglutide pharmacotherapy at my BMI and comorbidity profile after structured-program failure.
This is the FIRST request for this medication; I am not seeking a refill of a previously-approved course. The denial appears to be based on incomplete review of submitted documentation rather than on the cited criteria correctly applied.

═══════════════════════════════════════════════════════════════════════

REQUESTED REMEDY

1. Reverse the denial and approve the prior-authorization request for Wegovy 2.4 mg, 12-week initial supply.
2. Confirm reauthorization criteria for ongoing therapy (presumably continued documented weight loss and comorbidity improvement).
3. Resolve the appeal within 30 days for non-urgent or 72 hours for expedited review (this is a chronic-care therapy, expedited not requested).

═══════════════════════════════════════════════════════════════════════

LEGAL FRAMEWORK

This appeal is submitted under:
  - Plan internal-appeal procedures (Summary of Benefits and Coverage).
  - Affordable Care Act and 45 CFR §147.136 (timelines: 72-hour expedited / 30-day pre-service / 60-day post-service).
  - For ERISA-governed plans, 29 CFR §2560.503-1 (substantively similar timelines).
  - State law overlays as applicable (Oregon: ORS 743.804; expedited external review available).

If this internal appeal is denied, I intend to request external review through the Oregon Department of Consumer and Business Services (Insurance Division) and to consider state insurance-commissioner complaint.

═══════════════════════════════════════════════════════════════════════

ATTACHMENTS

Original prior-authorization request (sent by Dr. Chen 2026-04-15).
Denial letter dated 2026-04-22.
Clinical notes from Dr. Lin Chen, MD - OHSU (2024-12, 2025-08, 2026-03).
Lab results: A1C, comprehensive metabolic panel, lipid panel.
Weight-management program participation log (OHSU Wellness Clinic).
Letter of medical necessity from Dr. Chen, MD.
AGA 2022 clinical guideline excerpt supporting therapy.
ADA 2024-2025 Standards of Care excerpt.

═══════════════════════════════════════════════════════════════════════

I request acknowledgement of this appeal in writing within 7 days, with the assigned case number and the expected decision timeline.

Sincerely,


_______________________________            Date: June 19, 2026
Jordan Alex Taylor

About this template

Prior authorization (PA) denials for medications, procedures, and durable medical equipment are increasingly common as insurers tighten utilization-management criteria. The most-frequent denial categories: (1) "not medically necessary" - the insurer's clinical reviewer disagrees that the service meets the policy's necessity criteria; (2) "step-therapy required" - try a less-expensive alternative first; (3) "not a covered benefit" - the service isn't in the plan's formulary or benefit list; (4) "experimental/investigational" - the service lacks sufficient evidence of efficacy in the insurer's view. Each category has a different appeal strategy. Medical-necessity denials respond to detailed clinical documentation showing the patient meets the cited criteria - the most-common pattern is the insurer denying based on incomplete review of submitted records, and the appeal correcting that. Step-therapy denials succeed when the patient has documented failure or contraindication to the required prerequisites. Coverage denials require interpreting the plan benefit language. Experimental/investigational denials are the hardest - require citing peer-reviewed clinical guidelines (NCCN for oncology, AGA for GI, AHA/ACC for cardiology, etc.) showing the service is standard of care. ACA timeline rules apply: 72-hour decisions for expedited / pre-service urgent appeals, 30 days for pre-service non-urgent, 60 days for post-service. Most ACA non-grandfathered plans must offer external review (third-party Independent Review Organization, paid by insurer) after exhaustion of internal appeals; external reviewers reverse denials approximately 40-50% of the time per state DOI data. State Insurance Commissioners can investigate claim-handling and have authority to compel insurer cooperation.

When to use it

Prior-authorization denial for medication.
Pre-procedure denial of authorization.
Durable medical equipment (DME) denial.
Specialty drug step-therapy denial.
Experimental/investigational denial for evidence-supported therapy.

What to include

Member identification and policy/group numbers.
Specific service / drug / DME requested.
Ordering provider information.
Denial reason cited (verbatim from denial letter).
Medical-necessity argument with criteria-by-criteria response.
Specific requested remedy.
Citations to clinical guidelines.

Frequently asked

Under ACA: 72 hours for expedited / pre-service urgent; 30 days for pre-service non-urgent; 60 days for post-service. ERISA timelines are similar. Mark the appeal "URGENT" if a delay would jeopardise health (typical for serious conditions, post-surgery medication, ongoing therapy disruption).

⚠ Legal disclaimer. Health-insurance prior-authorization rules are complex and case-specific. ACA non-grandfathered plans, ERISA-governed employer plans, and grandfathered plans have different appeal frameworks. State law overlays (e.g., Oregon ORS 743.804, California Knox-Keene) add requirements. Internal-appeal deadlines (typically 180 days from denial) are firm. For complex denials or any case affecting urgent treatment, work with patient-advocacy organisations or healthcare attorneys. State DOI offices handle complaints and external review for state-regulated plans.

Jurisdiction: United States — Affordable Care Act §2719 internal-appeal + external-review rights (29 U.S.C. §1185d for ERISA plans; 42 U.S.C. §300gg-19 for non-grandfathered group/individual plans), 45 CFR §147.136 (4-month filing window for external review; expedited 72-hour review available for urgent care); ERISA §503 / 29 CFR §2560.503-1 (claim-procedure regulation including pre-service authorizations); state Independent Review Organization (IRO) statutes / NAIC Uniform Health Carrier External Review Model Act; URAC and NCQA accreditation standards for utilization review; state insurance-department prompt-payment + utilization-management statutes.

Last reviewed: 2026-05

Reviewed by ScoutMyTool — consult a licensed attorney for binding use.